Pharmaceutical Technology

MARCH 10, 2023

Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.

Manufacturing 147

Manufacturing Production Containment Antibody 147

STAT News

OCTOBER 25, 2022

The antitrust regulator in Spain has fined Merck approximately $39 million for preventing a competitor from marketing a generic version of a hormonal contraceptive, the latest effort by a European government to crack down on anti-competitive practices in the pharmaceutical industry. Continue to STAT+ to read the full story…

Regulation 98

Regulation Hormones Manufacturing Production 98

pharmaphorum

MAY 20, 2021

NICE has rejected Johnson & Johnson’s oral prostate cancer drug Erleada (apalutamide) in patients with hormone-relapsed or hormone sensitive disease in first draft guidance. Hormone relapsed disease has stopped responding to hormone therapy and is usually treated with ADT alone or with Bayer’s Nubeqa (darolutamide) and ADT.

Hormones 98

Hormones Drugs Trials Manufacturing 98

Roots Analysis

OCTOBER 24, 2023

Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.

Manufacturing 40

Manufacturing Hormones Contamination Containment 40

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under development for the treatment of non-metastatic castration-resistant prostate cancer, prostate cancer in patients with non-metastatic biochemical recurrence in the EU, China and Asia, and also for metastatic hormone-sensitive prostate cancer in the U.S,

Hormones 113

Hormones Contract Manufacturing Manufacturing Development 113

The Pharma Data

DECEMBER 18, 2020

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer. Indication.

Hormones 52

Hormones FDA Approval Containment Medicine 52

Pharmaceutical Technology

MAY 25, 2023

Mellozzan contains the sleep hormone melatonin and is indicated for use in children with attention deficit hyperactivity disorder (ADHD) and sleep difficulties. EQL Pharma will serve as manufacturer and supplier of the therapy for all third-party deals signed by Adalvo.

Hormones 130

Hormones Engineer Licensing Licensing 130

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under development for the treatment of non-metastatic castration-resistant prostate cancer, prostate cancer in patients with non-metastatic biochemical recurrence in the EU, China and Asia, and also for metastatic hormone-sensitive prostate cancer in the U.S,

Hormones 100

Hormones Contract Manufacturing Manufacturing Development 100

Pharmaceutical Technology

FEBRUARY 27, 2023

Enzalutamide is under development for the treatment of non-metastatic castration-resistant prostate cancer, prostate cancer in patients with non-metastatic biochemical recurrence in the EU, China and Asia, and also for metastatic hormone-sensitive prostate cancer in the U.S,

Hormones 100

Hormones Contract Manufacturing Manufacturing Development 100

XTalks

JANUARY 23, 2024

Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development. This rare endocrine disorder, characterized by inadequate secretion of growth hormone from the pituitary gland, has profound impacts on physical and sometimes cognitive development.

Development 72

Development Hormones Drugs Trials 72

Pharmaceutical Technology

MAY 31, 2023

Les Laboratoires Servier overview Les Laboratoires Servier (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company also provides generic drugs and contract development and manufacturing services across its global network.

Generic Drugs 100

Generic Drugs Hormones Manufacturing Development 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company also offers contract manufacturing and laboratory services. The company offers consumer, prescription and automation products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company also offers contract manufacturing and laboratory services. The company offers consumer, prescription and automation products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

pharmaphorum

SEPTEMBER 6, 2022

The health technology assessment (HTA) authority said that the PARP inhibitor “is not cost-effective at its current price” as a treatment for BRCA-positive prostate cancer that has spread to other parts of the body and relapsed after prior hormonal therapy.

Hormones 110

Hormones Drugs Manufacturing Research 110

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is indicated for the treatment of metastatic hormone sensitive prostate cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 100

Medicine Hormones Production Clinical Trials 100

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is indicated for the treatment of metastatic hormone sensitive prostate cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 100

Medicine Hormones Production Clinical Trials 100

BioTech 365

OCTOBER 14, 2020

… Continue reading →

Manufacturing 40

Manufacturing Production Marketing Hormones 40

XTalks

AUGUST 15, 2023

Preservatives and additives serve as routine ingredients for manufacturers, extending the shelf-life of food products. That’s because American pork contains growth hormones. One notable growth hormone, ractopamine, often employed in pig farming, has been banned in numerous countries. It’s not just used to wash chicken, either.

Hormones 98

Hormones Containment Production Packaging 98

Pharma Packaging Solutions

JUNE 30, 2023

Biopharmaceuticals, also called biologics, are drug products that are manufactured using biological sources. Hormones (such as insulin, glucagon, and growth hormone, to name a few) are produced by recombinant DNA, as are blood factors, thrombolytic agents, interferons, monoclonal antibodies, therapeutic enzymes, and more.

Recombinant DNA Technology 52

Recombinant DNA Technology Packaging Packaging Gene Therapy 52

Drug Discovery World

FEBRUARY 12, 2024

Membrane proteins are crucial molecules on the surface of cells with numerous biological functions, such as sensing hormones or cell communication. The Engineering Biology Mission Award was given by UK Research and Innovation (UKRI).

Research 105

Research Drugs Engineer Protein 105

The Pharma Data

MARCH 31, 2022

By investing into new technologies, automation, and digitalization, Bayer will implement a comprehensive program to substantially upscale its pharmaceutical manufacturing. Over the next three years Bayer will invest around 2 billion Euro into its manufacturing and supply chain capabilities.

Production 52

Production Manufacturing Hormones Gene Therapy 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Large-scale manufacturing. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector. Packaging. •

Marketing 130

Marketing Pharmacy Containment Sales 130

Drug Discovery World

NOVEMBER 29, 2022

The NHS hopes to offer the new drug to eligible prostate cancer patients within weeks, after the early access agreement was reached by NHS England and the drug’s manufacturer, Bayer and supported by NICE. .

Drugs 98

Drugs Hormones Manufacturing Research 98

Roots Analysis

JANUARY 23, 2024

Owing to the challenges involved in the synthesis process and demands of modern drug development, majority of drug developers in this domain prefer to outsource their development and manufacturing operations to peptide therapeutics contract API manufacturers as a strategic solution to streamline their research and peptide synthesis efforts.

Development 40

Development Contract Manufacturing Drugs Manufacturing 40

XTalks

SEPTEMBER 28, 2023

The discrepancy lies in the fact that American food manufacturers can use additives that are banned in Europe due to their associated significant health risks. This meant manufacturers could skip the FDA’s exhaustive safety review process, ensuring their products reached the market faster.

Hormones 52

Hormones Containment Production Cosmetics 52

FDA Law Blog

AUGUST 4, 2023

So, through DASCA, Congress targeted those who would circumvent the Controlled Substances Act (“CSA”) by manufacturing anabolic steroids with slightly different chemical structures from those expressly controlled by the CSA but which are intended to cause the same potentially harmful effects. at 50,039 codified at 21 C.F.R.

Hormones 52

Hormones Manufacturing Regulation Drugs 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

pharmaphorum

AUGUST 11, 2021

After rejecting Eli Lilly’s Verzenio for breast cancer therapy earlier this year, NICE has relented, recommending the drug for routine NHS use alongside hormonal therapy fulvestrant. The February decision to reject the twice-daily drug was described as a “devastating blow” by patient advocacy group Breast Cancer Now.

Hormones 63

Hormones Drugs Clinical Trials Clinical Trials 63

XTalks

JANUARY 24, 2022

Fooditive Group , a plant-based ingredient manufacturer, recently developed a vegan version of casein, one of the main animal proteins in milk. In developing the vegan casein, Fooditive aims to eradicate the downsides of factory farming, antibiotics, hormones and lactose.

Gene Splicing 112

Gene Splicing Protein Hormones Production 112

Pharma Packaging Solutions

NOVEMBER 8, 2023

Pre-filled Syringe Packaging A lot of biopharmaceutical products—such as insulin, vaccines, and many hormone therapies—are parenterally administered. At Tjoapack, we provide protective, versatile pre-filled syringe packaging options designed to get parenteral medications safely from the manufacturer to the consumer.

Packaging 52

Packaging Packaging Pharma Packaging Insulin 52

Drug Discovery World

APRIL 6, 2023

Men in England and Wales with advanced, incurable prostate cancer who have BRCA1/2 mutations in their tumours and who have seen their cancer progress despite hormone therapy will also have access to olaparib. NICE previously decided not to recommend the drug as a prostate cancer treatment due to the high cost of genetic testing.

Hormones 52

Hormones Gene Scientist Clinical Trials 52

XTalks

SEPTEMBER 24, 2020

Some of these chemicals are known endocrine (hormone) disruptors linked to developmental, cognitive and other health problems in babies and adults. In terms of the potential harms of food additives and packaging, synthetic chemicals that affect hormones have additive or synergistic effects.

Regulation 94

Regulation Hormones Containment Packaging 94

Pharmaceutical Technology

FEBRUARY 14, 2023

The company filed heterocyclic composition patents in areas such as PAD4 inhibitors, factor Xa inhibitors, and nuclear hormone receptor modulators. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects.

Antibody 130

Antibody Hormones DNA Licensing 130

Fossil Remedies

APRIL 7, 2020

Having headquarters in Ahmadabad, Gujarat, ‘ Fossil Remedies ’ is the top most Pharma franchises company in India with long years of experience.They manufacture and market more than 2800+ Pharma products and indulge in 8 Special divisions. 100+ Gynec & Hormones Products. They offer pharma franchise to interested parties.

Pharma Production 81

Pharma Production Pharma Companies Production Contract Manufacturing 81

XTalks

JUNE 5, 2023

Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the GLP-1 hormone released in the gastrointestinal tract after eating. Novo Nordisk, the pharmaceutical manufacturer of Ozempic and Wegovy, is actively addressing these supply challenges. There are safety concerns surrounding compounded semaglutide.

FDA Approval 98

FDA Approval Containment Drugs Pharmacy 98

XTalks

NOVEMBER 3, 2022

Although the company is planning to double capacity through a new manufacturing expansion in North Carolina planned for the end of 2023, company executives are warning of supply challenges.

Sales 98

Sales FDA Approval Production Insulin 98

XTalks

NOVEMBER 9, 2023

Zepbound contains mimetics of the GLP-1 and GIP hormones that regulate appetite and blood sugar. Both Novo and Lilly have been struggling on the manufacturing end amid growing demand for their GLP-1 agonists. The companies continue to roll out manufacturing expansion plans to help ramp up production.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59